Two blood markers moderately accurate in screening for Down syndrome

Two blood markers moderately accurate in screening for Down syndrome

Brian McAvoy
PEARLS No.
501
Clinical question

How accurate are first-trimester serum markers for the detection of Down syndrome in the antenatal period?

Bottom line

Tests involving 2 markers in combination with maternal age – specifically PAPP-A (pregnancy-associated plasma protein A), free beta-hCG (beta-human chorionic gonadotropin) and maternal age – were significantly better than those involving single markers, with and without age. They detected 7 out of 10 Down-affected pregnancies (3 in 10 were missed), and a fixed 5% of all tested women got a false-positive result. The addition of further markers (triple tests) was not shown to be statistically superior; the studies included were small, with limited power to detect a difference. The screening blood tests themselves had no adverse effects for the woman, over and above the risks of a routine blood test.

Caveat

Some women who have a “high risk” screening test result, and are given amniocentesis or chorionic villus sampling, have a risk of miscarriage of a baby unaffected by Down syndrome. Parents need to weigh up this risk when deciding whether or not to have amniocentesis or chorionic villus sampling following a “high risk” screening result.

Context

Down syndrome is the most common congenital cause of mental disability, and it also leads to numerous metabolic and structural problems. Non-invasive screening based on biochemical analysis of maternal serum or urine, or foetal ultrasound measurements, allows estimates of the risk of a pregnancy being affected, and provides information to guide decisions about definitive testing.

Cochrane Systematic Review

Review Alldred SK et al. First trimester serum tests for Down’s syndrome screening. Cochrane Reviews, 2015, Issue 11. Art. No.: CD011975.DOI: 10.1002/14651858. CD011975. This review contains 56 studies involving 204,759 participants (including 2113 with Down syndrome).

 

Cochrane Systematic Reviews for primary care practitioners
Developed by the Cochrane Primary Care Field, New Zealand Branch of the Australasian Cochrane Centre at the Department of General Practice and Primary Health Care, University of Auckland and funded by the Ministry of Health and New Zealand Doctor. PEARLS are meant for educational use and not to guide clinical care. New Zealanders can access the Cochrane Library free via www.cochrane.org.nz